オプションチェーンは、Culpの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Culpの市場センチメントを評価します。.

Culp (NYSE:CULP) 株価情報, オプションチェーン

Culp

Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.

Culp Inc

CULPEO MINERALS LTD by Culpeo Minerals Limited

Culpeo Minerals Ltd

On Wednesday, Advanced Micro Devices, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) <a target="_blank" href="https://www.benzinga.com/topic/amd" rel="noreferrer noopener">disclosed that it</a> had completed its initial assessment of a new license requirement implemented by the Trump administration for the export of certain semiconductor products to China (including Hong Kong and Macau) and D:5 countries, or to companies headquartered or with an ultimate parent <a target="_blank" href="https://ir.amd.com/financial-information/sec-filings/content/0000002488-25-000039/amd-20250415.htm" rel="noreferrer noopener">in such countries</a> (the &#8220;Export Control&#8221;).
The Export Control applies to the company&#8217;s MI308 products.
AMD expects to apply for licenses but there is no assurance that licenses will be granted.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44770461/intel-on-slump-as-china-hits-us-made-chips-with-tariffs-amd-and-taiwan-semiconductor-rise-on-exemption-boost" rel="noreferrer noopener">China Hits US-Made Chips With Tariffs, But Those Outsourcing To Taiwan Semiconductor Exempt</a>
It expects that the Export Control may incur up to approximately $800 million in inventory, purchase commitments, and related reserves.
AMD stock tanked 46% in the last 12 months as it grappled with rivalry from Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
AMD chief Lisa Su confirmed Tuesday <a target="_blank" href="https://www.benzinga.com/25/04/44815107/taiwan-semiconductor-preps-new-chip-tech-to-supercharge-ai-performance-by-2027" rel="noreferrer noopener">that&nbsp;the company</a> will manufacture more AI servers in the U.S.&nbsp;and begin chip production at&nbsp;Taiwan Semiconductor Manufacturing Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) Arizona facility.
President&nbsp;Donald Trump shared plans to slap tariffs on imported semiconductors on Sunday. He stressed the country&#8217;s focus on the domestic production of chips and semiconductors.
Wedbush analyst&nbsp;Daniel Ives cited AMD&nbsp;as <a target="_blank" href="https://www.benzinga.com/25/04/44720974/amd-powers-google-clouds-new-ai-servers-promising-80-boost-in-speed" rel="noreferrer noopener">among the&nbsp;vulnerable</a> tech companies, including&nbsp;Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)&nbsp;and Nvidia, after China&#8217;s finance ministry announced a 34%&nbsp;tariff on all goods imported&nbsp;from the U.S., effective April 10, in response to the U.S. administration&#8217;s 54% duties.
Jefferies analysts&nbsp;expect the&nbsp;tariffs&nbsp;to continue to put downward pressure on semiconductor stocks, including AMD.
<h2 class="wp-block-heading">Advanced Micro Devices Stock Prediction For 2025</h2>
Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.
Shares of Advanced Micro Devices have an average 1-year price target of $148.95, representing an expected upside of 66.26%.
Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. No analysts have bearish recommendations on Advanced Micro Devices, while 13 analysts have bullish ratings. The street high price target from Rosenblatt is $250.0, while the street low from Citigroup is $100.0.
Price Action: AMD stock is down 6.00% at $89.57 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/04/44821235/texas-instruments-launches-advanced-auto-chips-to-cut-costs-and-boost-self-driving-capabilities" target="_blank" rel="noreferrer noopener">Texas Instruments Launches Advanced Auto Chips To Cut</a></li>
</ul>
Photo by jamesonwu1972 via Shutterstock

Government

News

Regulations

Tech

AAPL

NVDA

AMD Flags $800 Million Risk From New US Chip Export Rules As China Tariffs Add Pressure

Shares of Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) tumbled more than 6% on Wednesday morning trading in New York after fresh U.S. export curbs on AI chips to China rattled the market, yet some Wall Street analysts see the pullback as <a href="https://www.benzinga.com/topic/expert-ideas">a rare buying opportunity.</a>
In a note shared Wednesday, Bank of America analyst Vivek Arya said the latest H20 chip restrictions to China, while unwelcome, were largely anticipated and pose only a "manageable risk" to Nvidia's sales outlook.
The investment bank reiterated a bullish stance on Nvidia, maintaining a Buy rating and a $160 price target, which implies a 42.6% upside from Tuesday's $112.20 close.
Despite a looming $5.5 billion charge and tighter U.S. export rules, Arya believes the company's deep AI moat and new product cycle could more than offset short-term pain.
<h3 class="wp-block-heading">Why Is Nvidia Taking A $5.5 Billion Hit?</h3>
Nvidia disclosed after the close on Tuesday that it will record a $5.5 billion first-quarter charge related to inventory, purchase commitments and reserves following a new U.S. government requirement. 
The policy mandates a license to ship H20 and equivalent AI chips to China and arms-embargoed countries.
The H20 chip, a specialized version of Nvidia's powerful AI hardware tailored to bypass earlier export rules, had emerged as a critical part of its China sales strategy. Yet, with the Trump administration tightening loopholes, those sales are in jeopardy.
Arya said the charge likely reflects "a high probability of H20 restriction" and a "low probability of future licenses," suggesting Nvidia has priced in the worst-case scenario.
<h3 class="wp-block-heading">How Much Could Nvidia Lose?</h3>
Bank of America estimates the H20 ban could lead to a manageable 5%-8% drop in sales and a 6%-10% hit to pro-forma earnings per share in fiscal year 2026 (calendar 2025). 
That's based on assumptions that H20 sales make up about 6%-10% of Nvidia's China revenue, which itself accounts for roughly 14% of total company sales.
Nvidia hasn't disclosed exact figures for H20, but Arya's model projects around $12 billion in sales from the chip for fiscal 2026—well above the $8 billion consensus from data platform Visible Alpha.
While the revenue loss is significant, Arya flagged positive offsets, including accelerating U.S. AI chip demand and strong pricing for Nvidia's next-generation GB300 Blackwell Ultra chips, which are expected to launch in the second half of 2025.
<h3 class="wp-block-heading">Is The Stock Undervalued?</h3>
Despite mounting geopolitical risks, Nvidia shares have already begun to price in much of the damage. According to Arya, the stock now trades at around 20 times expected 2025 earnings, down from its historical trough of 23-25 times.
He said that implies investors are now forecasting earnings of about $4 per share, well below the consensus estimate of $4.50 to $5. Arya argues this disconnect offers a compelling entry point, especially as AI chip demand from firms like OpenAI, Google, and Amazon remains robust.
"The global demand for leading-edge AI and Nvidia's unmatched platform leadership can continue to offset regional headwinds," Arya said.
<h3 class="wp-block-heading">What About Other Chipmakers?</h3>
The new rules won't just hit Nvidia. Arya said the increased AI export restrictions are likely to weigh on other semiconductor stocks with AI exposure, including Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), Arm Holdings Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>), Marvell Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>), Coherent Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NASDAQ">COHR</a>) and Lumentum Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>).
Washington may continue ratcheting up restrictions beyond China, and further controls could extend to semiconductor manufacturing equipment and design software, areas where the U.S. holds significant leverage.
Yet, despite the U.S.-China tech decoupling may be accelerating, Arya indicates the longer-term AI trend remains intact. 
"We believe AI remains the fastest growing secular growth opportunity in semis," he said, adding that recent volatility in Nvidia stock offers an &#8220;enhanced buying opportunity&#8221; rather than a reason to panic. 
Read now: 
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/04/44794083/7-chipmaker-stocks-set-to-gain-as-trump-delays-tariff-blow-on-key-china-tech-imports-bank-of-america">7 Chipmaker Stocks Set To Gain As Trump Delays Tariff Blow On Key China Tech Imports: Bank Of America</a></li>
</ul>
Image: Shutterstock

Analyst Color

Asia

Econ #s

Analyst Ratings

AVGO

COHR

LITE

MRVL

Nvidia H20 Chip Ban Could Lead To 'Manageable' Sales Drop, Bank Of America Says

Morgan Stanley analyst Hamza Fodderwala maintains Gen Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) with a Equal-Weight and lowers the price target from $27 to $25.

Price Target

Morgan Stanley Maintains Equal-Weight on Gen Digital, Lowers Price Target to $25

JP Morgan analyst David Karnovsky maintains Omnicom Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMC#NYSE">OMC</a>) with a Overweight and lowers the price target from $116 to $104.

JP Morgan Maintains Overweight on Omnicom Group, Lowers Price Target to $104

Morgan Stanley analyst Elizabeth Porter maintains Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) with a Equal-Weight and lowers the price target from $21 to $14.

FRSH

Morgan Stanley Maintains Equal-Weight on Freshworks, Lowers Price Target to $14

Morgan Stanley analyst Hamza Fodderwala maintains Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) with a Overweight and lowers the price target from $123 to $105.

FTNT

Morgan Stanley Maintains Overweight on Fortinet, Lowers Price Target to $105

Morgan Stanley analyst Lauren Lieberman maintains Five9 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>) with a Equal-Weight and lowers the price target from $48 to $28.

FIVN

Morgan Stanley Maintains Equal-Weight on Five9, Lowers Price Target to $28

JP Morgan analyst Alexander Hess maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Overweight and lowers the price target from $680 to $650.

MSCI

JP Morgan Maintains Overweight on MSCI, Lowers Price Target to $650

Morgan Stanley analyst Sanjit Singh maintains Fastly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) with a Equal-Weight and lowers the price target from $8 to $7.

FSLY

Morgan Stanley Maintains Equal-Weight on Fastly, Lowers Price Target to $7

Bernie Sanders didn't come to tiptoe around the issue. In a <a href="https://www.cnn.com/2025/04/09/politics/cnn-bernie-sanders-town-hall-takeaways/index.html">CNN town hall</a> moderated by Anderson Cooper last week, the 83-year-old independent senator from Vermont tore into President Donald Trump's government downsizing efforts — and the high-profile billionaire who's become the public face of them.
That billionaire is Elon Musk. He's supposedly not running the Department of Government Efficiency, but he's advising it — loudly. He's shown up to right-wing events with a chainsaw, backed sweeping cuts to federal jobs, and championed the administration's agenda to shrink the government. And to Sanders, Musk's growing role in public policy isn't just inappropriate — it's dangerous.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
"The idea that Musk goes around with his ‘chainsaw,'" Sanders said, referencing Musk's&nbsp; appearance at the Conservative Political Action Conference in February, "is outrageous." Then came the gut punch: "Am I going to tell you the Veterans Administration is the most efficient organization in the world? No, it's not. But you don't simply – with a chainsaw, if you like – <a href="https://www.benzinga.com/25/03/44442938/bernie-sanders-slams-plan-to-cut-83000-va-employees-you-do-not-balance-the-budget-on-the-backs-of-those-who-defended-this-country">get rid of 83,000 people</a>, then say, ‘Oh, it's not going to impact the quality of care that our veterans receive.'"
For Sanders, the stakes go far beyond government payrolls. He used the moment to warn what happens next — when <a href="https://www.benzinga.com/news/25/04/44757196/bernie-sanders-warns-the-job-you-have-today-aint-going-to-be-here-in-10-or-15-years-as-ai-and-robotics-threaten-us-workforce">technology and automation come for jobs</a>.
"If <a href="https://www.benzinga.com/news/25/02/43901182/bernie-sanders-warns-if-elon-musk-can-fire-hundreds-of-thousands-of-federal-employees-imagine-what-hell-do-to-private-sector-workers">Musk can do this to federal employees</a>, some of whom are in unions… what do you think he's going to be doing when artificial intelligence and robotics comes for your job?" he asked. "They don't give a damn about you. If this is what they can do to federal employees, think of what they can do to people in the private sector."
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
He didn't stop there. Sanders linked the job cuts and tech threats to what he's long called a "corrupt campaign finance system," pointing directly at Musk's influence in the 2024 presidential election and his threats to bankroll challengers. "When you talk about people losing faith in the American political system, it's justified," he said. "The average American says, ‘Yeah, I got one vote, and Musk can spend hundreds of millions of dollars. Is that a democracy? Why should I vote?'"
On trade, Sanders split from Trump's aggressive new round of tariffs. While he supports tariffs when they're "used selectively," he said Trump's approach was more about headlines than strategy. "To arbitrarily, out of nowhere, come up with a tariff that they can't even justify or explain to virtually every country on Earth is absolutely counterproductive."
He also shot down the White House's claim that iPhones could be made in the U.S. without fallout. Sanders said he wasn't sure how realistic that would be — but he knew the consequences: "immediate harm" to working people through higher prices.
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
Still, in a night heavy with economic critique, Sanders carved out space for something rare: a <a href="https://www.benzinga.com/25/04/44755507/therell-be-a-transition-cost-and-transition-problems-admits-trump-amid-tariff-woes-while-bessent-hints-at-negotiation-deals">call for global decency</a>. "We don't have to hate China. We don't have to hate other people," he said. "Let's figure out a way to work together." His bigger point: "The goal has got to be to break down these barriers that separate us as human beings — come together as Americans and come together globally as human beings."
But even his idealism was tethered to a stark warning. Sanders closed with a blunt assessment of Trump's power grabs, including lawsuits against the press, threats to universities, and talk of a third term. "What he wants is power and wealth for his oligarch friends," Sanders said. "This is whether or not we remain a free society. Or do we all bow down to our new king, President Trump? That is not the kind of nation I think we want to become."
He's older than he was during his 2016 rise — but Sanders is still swinging. And this time, the warning isn't just about billionaires or broken systems. It's about a chainsaw, a disappearing middle class, and a future being shaped without you in mind.
Read Next:
<ul>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.</li>
<li>With shares starting at $1.52, <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">this could be your chance to invest in the future of healthcare</a>.</li>
</ul>

Personal Finance

'They Don't Give a Damn About You' —Bernie Sanders Says If Musk Is Firing Federal Workers With a Chainsaw, What Happens When AI Comes For Your Job?

Corcept Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) has outperformed the market over the past 20 years by 7.21% on an annualized basis producing an average annual return of 15.13%. Currently, Corcept Therapeutics has a market capitalization of $7.34 billion. 
Buying $1000 In CORT: If an investor had bought $1000 of CORT stock 20 years ago, it would be worth $16,746.85 today based on a price of $69.59 for CORT at the time of writing.
<h3>Corcept Therapeutics's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744818312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CORT

$1000 Invested In Corcept Therapeutics 20 Years Ago Would Be Worth This Much Today

Morgan Stanley analyst Sanjit Singh maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Overweight and lowers the price target from $140 to $120.

ESTC

Morgan Stanley Maintains Overweight on Elastic, Lowers Price Target to $120

JP Morgan analyst Andrew Steinerman maintains Moodys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) with a Overweight and lowers the price target from $585 to $495.

JP Morgan Maintains Overweight on Moodys, Lowers Price Target to $495

GeneDx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSG#NASDAQ">WSG</a>) announced plans on Wednesday to <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44833392/genedx-to-acquire-fabric-genomics-enabling-decentralized-ai-powered-testing-at-global-scale" rel="noreferrer noopener">acquire Fabric Genomics</a>, a pioneer in AI-powered genomic interpretation, to create a leading platform for rare disease diagnostics and newborn screening.
Under the agreement, GeneDx will pay up to $33 million in cash at closing, with the total consideration potentially reaching $51 million upon achieving certain milestones.
The acquisition is expected to accelerate genomic newborn screening, enhance NICU testing capabilities, and expand GeneDx&#8217;s global reach through on-site sequencing and remote interpretation.
By integrating Fabric&#8217;s cloud-native, decentralized platform, GeneDx will be able to offer flexible, regulation-compliant services worldwide and transform its vast dataset into a scalable, recurring revenue model.
&#8220;Healthcare is at an inflection point where integrating genomic insights into standard care is becoming essential – both for better clinical outcomes and for saving the healthcare system valuable dollars,&#8221; said Katherine Stueland, President and CEO of GeneDx. &#8220;Adding Fabric Genomics and their talented team moves us closer to that future, enabling our partners to deliver groundbreaking genomic insights to patients across the globe.&#8221;
Stueland added that the combined platform will support faster, more accurate, and accessible genomic analysis, helping to proactively deliver precision diagnostics without geographic limitations.
As of December 31, 2024, GeneDx held <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43775587/genedx-reports-fourth-quarter-and-full-year-2024-financial-results-and-issues-guidance-for-full-ye" rel="noreferrer noopener">$142.2 million</a> in cash, cash equivalents, marketable securities, and restricted cash.
Additionally, April saw GeneDx <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44625404/genedx-expands-commercial-footprint-for-exome-and-genome-testing-with-inborn-errors-of-immunity-as" rel="noreferrer noopener">expand </a>into Inborn Errors of Immunity, offering exome and genome testing for over 200,000 U.S. patients. The move enhances diagnostic accuracy, accelerates treatment, and opens new opportunities with biopharma partners to advance precision medicine in inherited immune disorders.
Price Action: WGS shares are trading lower by 1.72% at $100.47 at the last check on Wednesday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44841871/lyft-expands-to-europe-with-e175m-freenow-acquisition-targets-bookings-by-e1b-annually">BMW, Mercedes-Benz Sell Taxi App To Lyft For $197M: CEO Says Entering Europe Is &#8216;Important Step&#8217;</a></li>
</ul>

GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million

RBC Capital analyst Gerard Cassidy maintains PNC Financial Services Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) with a Outperform and lowers the price target from $205 to $195.

RBC Capital Maintains Outperform on PNC Financial Services Gr, Lowers Price Target to $195

Morgan Stanley analyst Chris Quintero maintains E2open Parent Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) with a Equal-Weight and lowers the price target from $3 to $2.3.

ETWO

Morgan Stanley Maintains Equal-Weight on E2open Parent Holdings, Lowers Price Target to $2.3

Morgan Stanley analyst Sanjit Singh maintains Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) with a Equal-Weight and lowers the price target from $62 to $50.

Morgan Stanley Maintains Equal-Weight on Dynatrace, Lowers Price Target to $50

Morgan Stanley analyst Sanjit Singh maintains Domo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOMO#NASDAQ">DOMO</a>) with a Equal-Weight and lowers the price target from $9 to $8.

DOMO

Morgan Stanley Maintains Equal-Weight on Domo, Lowers Price Target to $8

Morgan Stanley analyst Josh Baer maintains Docusign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) with a Equal-Weight and lowers the price target from $97 to $92.

DOCU

Morgan Stanley Maintains Equal-Weight on Docusign, Lowers Price Target to $92

Morgan Stanley analyst Josh Baer maintains Docebo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCBO#NASDAQ">DCBO</a>) with a Overweight and lowers the price target from $43 to $41.

DCBO

Morgan Stanley Maintains Overweight on Docebo, Lowers Price Target to $41

Press Releases

Culp, Inc. to Webcast Fourth Quarter and Fiscal 2024 Conference Call

Culp Announces Results for Fourth Quarter and Fiscal 2024, Provides Update on Restructuring Initiatives

Culp Names Mary Beth Hunsberger as President of Culp Upholstery Fabrics

Culp, Inc. to Webcast First Quarter Fiscal 2025 Conference Call

Culp Announces Results for First Quarter Fiscal 2025, Highlighted by a 14.2% Sequential Increase in Sales and Stable Cash Position

Culp, Inc. to Webcast Second Quarter Fiscal 2025 Conference Call

Culp Announces Results for Second Quarter Fiscal 2025, Highlighted by Sequential Improvement in Mattress Fabrics Performance, Along With Steady Restructuring Progress

Culp, Inc. to Webcast Third Quarter Fiscal 2025 Conference Call

Culp Announces Results for Third Quarter Fiscal 2025, Highlighted by Continued Improvement in Mattress Fabrics Operating Performance and Execution on Restructuring Initiatives

Comments

Culp

Culp (CULP) オプション

Culp (NYSE:CULP) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル